Title : Potential biomarker for aspirin use in colorectal cancer therapy.

Pub. Date : 2013 Jan

PMID : 23207797






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Patients with colorectal cancer with mutated PIK3CA, identified from two large observational cohorts, had increased cancer-specific and overall survival if they used aspirin regularly after diagnosis compared to non-users. Aspirin phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha Homo sapiens
2 Mutated PIK3CA might be a useful biomarker to select patients who would benefit from adjuvant aspirin therapy. Aspirin phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha Homo sapiens